News at GASCO
GASCO Newsletters
GASCO publishes its GASCO Hot Topics Newsletter every other month.
New Blood Test for Colon Cancer Screening
Simplify your screening. A new blood test for colon cancer screening is now available in Atlanta. GuardantHealth's Shield, a non-invasive alternative to traditional methods, could save lives by detecting early signs of colon cancer. A huge step forward for preventative care.
Job Board for Member Practices
As a courtesy service for GASCO members, GASCO is providing this Job Board which lists open positions as provided by GASCO member practices.
FDA Drug Approvals
See a list of recent GASCO Corporate Member FDA approvals for drugs and new indications.
Multiple Myeloma Research Fund Walk/Run
When: October 6, 2024 • 8:20 a.m.
Where: Westside Park
Honorary Event Chair: Dr. Sagar Lonial, Winship Cancer Institute at Emory
Website: https://themmrf.org/Atl24
Contact: Brianna Dragunoff at dragunoffb@themmrf.org
ADC Cast - Expert discussions on antibody drug conjugates
'ADC Cast' is a non-promotional educational podcast series dedicated to antibody drug conjugates (ADCs). Hosted by Dr Javier Cortés and Prof. Peter Schmid, joined by an international panel of experts in ADCs and breast cancer, this educational podcast series unveils invaluable insights into ADCs. Throughout this podcast series our experts delve into crucial topics surrounding ADCs in breast cancer, shedding light on their developmental history, discussing their distinctive structural features and mechanisms of action, and exploring potential future advancements of ADCs.
This is a non-promotional educational podcast series dedicated to US healthcare professionals only. This podcast series was funded and produced by Gilead Sciences, Inc. © 2024 Gilead Sciences, Inc. All rights reserved.
GILEAD and the GILEAD logo are trademarks of Gilead Sciences, Inc. MA-UNB-NA-US-00112 07/24
Georgia's First Statewide Clinical Trials Navigator (CTN) Program
Helping patients by helping providers identify clinical trials.
ASCO & JCO Cancer Portals
Your one-stop resource for the latest disease-specific abstracts, videos, guidelines, and articles.
Winship Community Outreach and Engagement (COE) Community Cancer Mini-Grants
The Winship Cancer Institute of Emory University and its Community Outreach and Engagement (COE) component are pleased to release the Summer 2024 Request for Pilot Grant Proposals for its Community Cancer Mini-Grants pilot project program. The COE's Community Cancer Mini-Grants is a peer-reviewed program that provides pilot funding for projects that implement and evaluate evidence-based interventions to improve community assessment, access, and/or outcomes related to cancer. Winship Cancer Institute of Emory University is Georgia's only National Cancer Institute-designated Comprehensive Cancer Center. This program enables Georgia-based community organizations to obtain funding to implement and evaluate an evidence-based intervention that may focus on cancer prevention, risk reduction, access to screening or treatment, survivorship, or policy that has the potential to impact the community. Winship COE Community Cancer Mini-Grants provide two funding opportunities every year. Successful applications are supported by funds from the Winship's NCI Cancer Center Support Grant (CCSG), with additional support from philanthropy.
Oncology Changes in CPT 2024 Code Set Include Common Treatments, Lab Tests
The CPT 2024 code set contains 230 additions, 49 deletions, and 70 revisions. Oncology changes include chemotherapy code revisions and pathology/lab additions.
Standing in the Gaap
African Americans with multiple myeloma are:
- More likely to be diagnosed.
- Less likely to get treatment.
Multiple myeloma is the most common form of blood cancer in African Americans.
- Multiple myeloma is about 2X more common in African Americans vs White Americans. In fact, 1 in 5 people with multiple myeloma is African American.
- Diagnosing multiple myeloma can be tricky in anyone. But the time it takes to get diagnosed is typically longer for African Americans.
- African Americans are less likely to get certain treatments. However, when receiving the same treatment, African Americans do just as well as and sometimes better than White Americans
Stand Up for Care and Stand in the Gaap with Us
The Standing in the Gaap initiative was created with one goal in mind: to help improve the care of African Americans living with multiple myeloma.
Visit https://www.myelomacentral.com/africanamericans and and help spread the word.
MyHealthcareFinances
Pfizer has partnered with Triage Cancer to create MyHealthcareFinances.com, a freely available website that helps patients and caregivers understand finances related to healthcare, and steps to take that may help lower their costs.
The goal is to provide an overview of key topics that may be helpful to point individuals in the right direction on where to find more information. By using this tool, it is believed patients can take an important step to help empower their path forward.
MyHealthcareFinances is a collaboration between Pfizer and Triage Cancer, which joins people with a shared passion for improving healthcare-related financial literacy.
